Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80232662 | 8023266 | 2 | F | 20100411 | 20160812 | 20110706 | 20160823 | EXP | JP-PFIZER INC-JP-WYE-H18222810 | PFIZER | 77.00 | YR | F | Y | 54.00000 | KG | 20160823 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80232662 | 8023266 | 1 | PS | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous drip | 4.5 G, 3X/DAY | 337.5 | G | Y | 50684 | 4.5 | G | INJECTION | TID | |||
| 80232662 | 8023266 | 2 | SS | LOXONIN | LOXOPROFEN SODIUM | 1 | Oral | 180 MG, 1X/DAY | 4140 | MG | Y | 0 | 180 | MG | QD | ||||
| 80232662 | 8023266 | 3 | SS | LOXONIN | LOXOPROFEN SODIUM | 1 | UNK | 4140 | MG | Y | 0 | ||||||||
| 80232662 | 8023266 | 4 | C | CEFAZOLIN SODIUM. | CEFAZOLIN SODIUM | 1 | Intravenous drip | 2 G, 1X/DAY | 32 | G | 0 | 2 | G | QD | |||||
| 80232662 | 8023266 | 5 | C | CEFAZOLIN SODIUM. | CEFAZOLIN SODIUM | 1 | 32 | G | 0 | ||||||||||
| 80232662 | 8023266 | 6 | C | VANCOMYCIN /00314402/ | VANCOMYCIN | 1 | Intravenous drip | 1.5 G, 1X/DAY | 0 | 1.5 | G | QD | |||||||
| 80232662 | 8023266 | 7 | C | ROPION | FLURBIPROFEN AXETIL | 1 | Intravenous drip | 50 MG, 1X/DAY | 1050 | MG | 0 | 50 | MG | QD | |||||
| 80232662 | 8023266 | 8 | C | ROPION | FLURBIPROFEN AXETIL | 1 | 1050 | MG | 0 | ||||||||||
| 80232662 | 8023266 | 9 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 200 MG, 1X/DAY | 600 | MG | 0 | 200 | MG | QD | |||||
| 80232662 | 8023266 | 10 | C | AZULENE SODIUM SULFONATE/LEVOGLUTAMIDE | 2 | Oral | 2.01 G, 1X/DAY | 6.0300002 | G | 0 | 2.01 | G | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 80232662 | 8023266 | 1 | Post procedural infection |
| 80232662 | 8023266 | 2 | Antipyresis |
| 80232662 | 8023266 | 3 | Analgesic therapy |
| 80232662 | 8023266 | 4 | Infection prophylaxis |
| 80232662 | 8023266 | 5 | Post procedural infection |
| 80232662 | 8023266 | 6 | Post procedural infection |
| 80232662 | 8023266 | 7 | Postoperative analgesia |
| 80232662 | 8023266 | 8 | Antipyresis |
| 80232662 | 8023266 | 9 | Antipyresis |
| 80232662 | 8023266 | 10 | Gastric disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 80232662 | 8023266 | LT |
| 80232662 | 8023266 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 80232662 | 8023266 | Arrhythmia | |
| 80232662 | 8023266 | Cardiac failure | |
| 80232662 | 8023266 | Gastroduodenal ulcer | |
| 80232662 | 8023266 | Tubulointerstitial nephritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 80232662 | 8023266 | 1 | 20100318 | 20100412 | 0 | |
| 80232662 | 8023266 | 2 | 20100226 | 20100320 | 0 | |
| 80232662 | 8023266 | 3 | 20100409 | 20100412 | 0 | |
| 80232662 | 8023266 | 4 | 20100225 | 20100312 | 0 | |
| 80232662 | 8023266 | 6 | 20100318 | 0 | ||
| 80232662 | 8023266 | 7 | 20100318 | 20100407 | 0 | |
| 80232662 | 8023266 | 9 | 20100407 | 20100409 | 0 | |
| 80232662 | 8023266 | 10 | 20100409 | 20100412 | 0 |